Undecylenic Acid in Kerassentials: The 5% Label
A named percentage makes this ingredient different from the rest of the pictured panel. Concentration, labeling and intended use determine what can reasonably be inferred.
A named percentage makes this ingredient different from the rest of the pictured panel. Concentration, labeling and intended use determine what can reasonably be inferred.
What the Kerassentials label actually tells us
Undecylenic acid is a fatty-acid-derived substance with a history in topical antifungal preparations. The 5% printed on the supplied bottle must be read carefully because the FDA OTC monograph for particular antifungal indications specifies 10–25% total undecylenate. That comparison does not establish this finished product’s regulatory status or clinical outcome.
| Label figure | 5% undecylenic acid USP |
|---|---|
| Independent context | 10–25% range appears in FDA monograph for certain OTC antifungals |
| Gap | No clinical outcomes for this 15 mL formula supplied |
What the 5% label figure does—and does not—say
Undecylenic acid is listed as USP (5%) on the photographed Kerassentials label. The FDA OTC antifungal monograph discusses a 10–25% total undecylenate concentration for specified drug indications. The figures refer to different contexts; the label alone does not establish the finished product’s drug classification or clinical effectiveness.
Why a concentration is not an efficacy result
The 5% figure is a formulation disclosure, not the amount absorbed into nail tissue or the proportion of fungal infections cleared. Nail thickness, the vehicle and contact conditions influence drug delivery. Any claim to eliminate a confirmed nail infection would need appropriately designed evidence about the finished formula.
Source context: FDA OTC monograph M005 · AAD diagnosis and treatment
FDA monograph versus finished-product evidence
FDA administrative order M005 describes certain OTC topical antifungal drugs. Matching or differing from one ingredient range cannot substitute for examining product labeling, claims, and regulatory requirements. The site does not claim that Kerassentials itself is approved, clinically tested or proven ineffective on this numerical comparison alone.
The practical question for an affected nail
For a discolored or thickened toenail, the first decision is whether infection is actually present. The American Academy of Dermatology explains that a clinician may inspect and sample the nail, then choose treatment suited to the organism and nail involvement.
Comparing percentages correctly
The exact label states 5% undecylenic acid USP. The FDA OTC topical antifungal monograph specifies 10–25% total undecylenate for certain antifungal drug products. These figures cannot be merged into a simple “half strength” effectiveness claim. Whether a product fits a particular regulatory pathway depends on more than the numerical concentration. A buyer should ask what indications are being made, what clinical evidence supports them and whether the bottle’s labeling reflects the appropriate regulatory category.
Undecylenic-acid evidence checklist
Verify the printed concentration on your own bottle, distinguish an external-use cosmetic claim from a treatment claim, look for research using the exact Kerassentials formula, and ask whether a clinician should assess the nail before self-treatment.
References & verification
- Supplied product-label image
- FDA OTC topical antifungal administrative order M005
- American Academy of Dermatology: Nail fungus diagnosis & treatment
- DermNet: Allergic contact dermatitis to essential oils
Sources are linked so readers can distinguish a label fact, seller policy and independent medical guidance. An ingredient study does not establish product-level effectiveness.